Novo Nordisk and a popular virtual health company are making Wegovy more accessible to millions of more Americans.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...

Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

The maker of Wegovy is making the GLP-1 medication available to several telehealth companies to make it more affordable for those paying out of pocket.

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers, Ro and LifeMD to sell branded versions of ...

Americans are grabbing for snacks less – and it appears to be for a variety of reasons, including worries about money, the desire to eat healthier and reduce artificial dyes as well as the increased ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.